Compare with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

KRSNAA DIAGNOSTICS vs DR LALCHANDANI LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    KRSNAA DIAGNOSTICS DR LALCHANDANI LABS KRSNAA DIAGNOSTICS/
DR LALCHANDANI LABS
 
P/E (TTM) x - - - View Chart
P/BV x 10.1 2.5 400.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 KRSNAA DIAGNOSTICS   DR LALCHANDANI LABS
EQUITY SHARE DATA
    KRSNAA DIAGNOSTICS
Mar-21
DR LALCHANDANI LABS
Mar-20
KRSNAA DIAGNOSTICS/
DR LALCHANDANI LABS
5-Yr Chart
Click to enlarge
High RsNA22 0.0%   
Low RsNA8 0.0%   
Sales per share (Unadj.) Rs998.814.1 7,085.4%  
Earnings per share (Unadj.) Rs284.51.1 25,989.7%  
Cash flow per share (Unadj.) Rs342.12.1 16,514.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %NM0- 
Book value per share (Unadj.) Rs355.519.7 1,802.0%  
Shares outstanding (eoy) m6.504.33 150.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x01.1 0.0%   
Avg P/E ratio x013.6 0.0%  
P/CF ratio (eoy) x07.2 0.0%  
Price / Book Value ratio x00.8 0.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m065 0.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2966 5,227.2%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,49261 10,636.3%  
Other income Rs m1220-   
Total revenues Rs m6,61561 10,836.8%   
Gross profit Rs m3,46613 27,312.5%  
Depreciation Rs m3744 8,850.8%   
Interest Rs m2592 14,021.6%   
Profit before tax Rs m2,9557 44,697.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,1052 59,103.2%   
Profit after tax Rs m1,8495 39,014.6%  
Gross profit margin %53.420.8 256.8%  
Effective tax rate %37.428.2 132.6%   
Net profit margin %28.57.8 366.6%  
BALANCE SHEET DATA
Current assets Rs m2,48176 3,281.4%   
Current liabilities Rs m1,83819 9,898.0%   
Net working cap to sales %9.993.5 10.6%  
Current ratio x1.44.1 33.2%  
Inventory Days Days2533 74.4%  
Debtors Days Days41199 20.5%  
Net fixed assets Rs m3,56440 8,843.5%   
Share capital Rs m2,48943 5,743.9%   
"Free" reserves Rs m-17842 -424.0%   
Net worth Rs m2,31085 2,705.1%   
Long term debt Rs m1,68015 11,535.3%   
Total assets Rs m6,045119 5,065.6%  
Interest coverage x12.44.6 270.9%   
Debt to equity ratio x0.70.2 426.4%  
Sales to assets ratio x1.10.5 210.0%   
Return on assets %34.95.5 631.5%  
Return on equity %80.05.6 1,441.5%  
Return on capital %80.58.5 952.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m00-   
Fx outflow Rs m00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m1,026-1 -105,729.9%  
From Investments Rs m-611-5 11,557.5%  
From Financial Activity Rs m3089 3,607.0%  
Net Cashflow Rs m7232 31,554.1%  

Share Holding

Indian Promoters % 27.4 60.8 45.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 36.2 0.0 -  
FIIs % 6.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 72.6 39.2 185.2%  
Shareholders   75,554 151 50,035.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare KRSNAA DIAGNOSTICS With:   DHANVANTRI JEEV  AASHKA HOSPITALS  TEJNAKSH HEALTHCARE  FORTIS HEALTHCARE  ARTEMIS MEDICARE SERVICES  



Today's Market

5 Reasons Why Sensex Slumped 949 Points Today(Closing)

Indian share markets witnessed huge selling pressure today and ended deep in the red.

Related Views on News

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

Block Deal Disappoints Max Healthcare Shareholders. Stock Falls 6% (Views On News)

Sep 30, 2021

The divestment of 6.6% stake by the promoter is considered to be one of the largest block deals of the market.

More Views on News

Most Popular

Infosys vs TCS: Which is Better?(Views On News)

Nov 26, 2021

In the post pandemic era, the top two IT companies in India are fighting to capture the growing demand for IT.

This Multibagger Stock Zooms 20% After Dolly Khanna Buys Stake(Views On News)

Nov 24, 2021

Shares of this edible oil company zoomed over 50% in three days after ace investor bought around 1% stake.

6 Popular Stocks that Turned into Penny Stocks(Views On News)

Nov 27, 2021

A look at popular stocks that crashed big time and never recovered, i.e. which went from 'Multibaggers to Multibeggers'.

India's Top 5 Monopoly Stocks to Watch Out for(Views On News)

Nov 30, 2021

These 5 companies dominate their sectors with a huge piece of the pie.

5 Indian Companies Embracing Blockchain Technology(Views On News)

Nov 23, 2021

Blockchain adoption in India was slow in the past. Now, the technology is being well received.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

KRSNAA DIAGNOSTICS SHARE PRICE


Dec 6, 2021 (Close)

TRACK KRSNAA DIAGNOSTICS

  • Track your investment in KRSNAA DIAGNOSTICS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON KRSNAA DIAGNOSTICS

KRSNAA DIAGNOSTICS 5-YR ANALYSIS

COMPARE KRSNAA DIAGNOSTICS WITH

MARKET STATS